Free shipping on all orders over $ 500

LY2608204

Cat. No. M3562

All AbMole products are for research use only, cannot be used for human consumption.

LY2608204 Structure
Synonym:

Globalagliatin

Size Price Availability
5mg USD 150 1-2 Weeks
10mg USD 240 1-2 Weeks
50mg USD 750 1-2 Weeks
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

LY2608204 is a potent used to treat type 2 diabetes. In a clinical trial, a study was performed to evaluate the safety and tolerability of LY2608204 in patients with type 2 diabetes.

Protocol (for reference only)
Cell Experiment
Cell lines
Preparation method
Concentrations
Incubation time
Animal Experiment
Animal models Male Wistar rats at a weight of 225-250 g
Formulation LY2608204 is suspended in a 1:1 mixture of solutol/ethanol in a bath sonicator (10% of total volume). The obtained suspension is then diluted with 9 volumes of 10% aqueous solutol solution.
Dosages 1, 3, 6, 10, 20 and 30 mg/kg
Administration Orally, rats are given a 2 g/kg oral glucose bolus 2 hours after LY2608204 administration.
Chemical Information
Molecular Weight 559.81
Formula C28H37N3O3S3
CAS Number 1234703-40-2
Form Solid
Solubility (25°C) DMSO 100 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Manoj Kumar Gupta, et al. Insights into the structure-function relationship of both wild and mutant zinc transporter ZnT8 in human: a computational structural biology approach

Related Glucokinase (GK) Products
AM2394

AM-2394 is a structurally distinct glucokinase activator (GKA). AM-2394 activates glucokinase (GK) with an EC50 of 60 nM.

Dorzagliatin

Dorzagliatin (HMS-5552, RO-5305552, Sinogliatin) is a glucokinase (GK) activator, which improves glycaemic control and pancreatic β-cell function for type 2 diabetes.

AZD1656

AZD1656 is a potent, selective and orally active glucokinase (GK) activator, with an EC50 of 60 nM.

Cadisegliatin (TTP-399)

Cadisegliatin (TTP-399) is a potential, orally active liver-selective glucokinase (GK) activator. Cadisegliatin has antihyperglycaemic activity. Cadisegliatin can be used for the research of type 2 diabetes.

  Catalog
Abmole Inhibitor Catalog




Keywords: LY2608204, Globalagliatin supplier, Glucokinase (GK), inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.